CAD 0.05
(0.0%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 8.53 Million CAD | 19.36% |
2022 | 7.15 Million CAD | -22.2% |
2021 | 9.19 Million CAD | -6.01% |
2020 | 9.78 Million CAD | -1.99% |
2019 | 9.97 Million CAD | 97.09% |
2018 | 5.06 Million CAD | 929.7% |
2017 | 491.73 Thousand CAD | 296.99% |
2016 | 123.86 Thousand CAD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 9.62 Million CAD | 5.61% |
2024 Q1 | 9.11 Million CAD | 6.71% |
2024 Q3 | 9.05 Million CAD | -5.88% |
2023 Q4 | 8.53 Million CAD | 12.29% |
2023 Q3 | 7.6 Million CAD | 11.18% |
2023 FY | 8.53 Million CAD | 19.36% |
2023 Q1 | 6.88 Million CAD | -3.72% |
2023 Q2 | 6.83 Million CAD | -0.69% |
2022 FY | 7.15 Million CAD | -22.2% |
2022 Q3 | 7.87 Million CAD | -10.77% |
2022 Q2 | 8.82 Million CAD | -8.56% |
2022 Q1 | 9.64 Million CAD | 4.93% |
2022 Q4 | 7.15 Million CAD | -9.13% |
2021 Q4 | 9.19 Million CAD | -12.04% |
2021 Q3 | 10.45 Million CAD | 0.29% |
2021 Q2 | 10.42 Million CAD | 30.23% |
2021 FY | 9.19 Million CAD | -6.01% |
2021 Q1 | 8 Million CAD | -18.19% |
2020 Q3 | 10.6 Million CAD | 22.05% |
2020 FY | 9.78 Million CAD | -1.99% |
2020 Q4 | 9.78 Million CAD | -7.81% |
2020 Q2 | 8.69 Million CAD | -5.68% |
2020 Q1 | 9.21 Million CAD | -7.65% |
2019 Q4 | 9.97 Million CAD | -10.56% |
2019 Q3 | 11.15 Million CAD | 35.82% |
2019 Q2 | 8.21 Million CAD | 2704.2% |
2019 Q1 | 292.95 Thousand CAD | -30.18% |
2019 FY | 9.97 Million CAD | 97.09% |
2018 Q1 | - CAD | -100.0% |
2018 Q2 | 491.73 Thousand CAD | 0.0% |
2018 Q3 | 475.63 Thousand CAD | -3.28% |
2018 Q4 | 419.59 Thousand CAD | -11.78% |
2018 FY | 5.06 Million CAD | 929.7% |
2017 Q3 | 264 Thousand CAD | 0.0% |
2017 FY | 491.73 Thousand CAD | 296.99% |
2017 Q4 | 534.93 Thousand CAD | 102.62% |
2016 FY | 123.86 Thousand CAD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Aion Therapeutic Inc. | 210.67 Thousand CAD | -3952.287% |
Ayurcann Holdings Corp. | 14.85 Million CAD | 42.527% |
Blueberries Medical Corp. | 2.41 Million CAD | -253.257% |
The BC Bud Corporation | 632.06 Thousand CAD | -1250.656% |
BioNxt Solutions Inc. | 1.26 Million CAD | -573.503% |
CordovaCann Corp. | 10.26 Million CAD | 16.823% |
Christina Lake Cannabis Corp. | 15.96 Million CAD | 46.518% |
Captor Capital Corp. | 33.85 Million CAD | 74.783% |
City View Green Holdings Inc. | 3846.00 CAD | -221871.789% |
1CM Inc. | 34.01 Million CAD | 74.905% |
Global Hemp Group Inc. | 42.76 Thousand CAD | -19864.535% |
Greenway Greenhouse Cannabis Corporation | 33.08 Million CAD | 74.2% |
IM Cannabis Corp. | 48.81 Million CAD | 82.511% |
Lobe Sciences Ltd. | 2.29 Million CAD | -271.258% |
Maple Leaf Green World Inc. | 168.27 Thousand CAD | -4973.324% |
Mountain Valley MD Holdings Inc. | 8.96 Million CAD | 4.784% |
Ovation Science Inc. | 76.88 Thousand CAD | -11003.209% |
Pharmadrug Inc. | 1.45 Million CAD | -484.854% |
Captiva Verde Wellness Corp. | 9.1 Million CAD | 6.21% |
RAMM Pharma Corp. | 32.3 Million CAD | 73.57% |
RIV Capital Inc. | 1.74 Million CAD | -390.479% |
Revive Therapeutics Ltd. | 10.63 Million CAD | 19.734% |
Red White & Bloom Brands Inc. | 234.25 Million CAD | 96.356% |
SLANG Worldwide Inc. | 33.2 Million CAD | 74.288% |
1933 Industries Inc. | 18.01 Million CAD | 52.624% |
Red Light Holland Corp. | 24.08 Million CAD | 64.553% |
Top Strike Resources Corp. | 11.73 Million CAD | 27.253% |
Xebra Brands Ltd. | 379.36 Thousand CAD | -2150.331% |
Adastra Holdings Ltd. | 32.34 Million CAD | 73.605% |